To gauge the comparative level of CD40L expression in patients with BD, we quantified sCD40L in patients with iSLE and patients with aSLE, whose CD40L expression is known to be highly upregulated in CD4+ T cells and even aberrantly expressed on CD8+ T cells, B cells, and monocytes [27, 28]. The gene discussed is CD4; the disease is Behcet disease.